Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial

Journal:

Nature Medicine

Published:

2025-06-03

DOI:

10.1038/s41591-025-03739-y

Affiliations:

7

Authors:

37

Go to article

Institutions	Authors	Share
University of Science, Technique and Technologies of Bamako (USTTB), Mali	19.000000 19.000000	0.51
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	10.000000 10.000000	0.27
University of Washington (UW), United States of America (USA)	4.500000	0.12
Harvard University, United States of America (USA)	3.000000	0.08
Seattle Children's Hospital, United States of America (USA)	0.500000	0.01

Interested in Immunology?